Baudax Bio, Inc.
BXRX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1,055 | $16,783 | $18,827 | $64,696 |
| - Cash | $5,259 | $15,891 | $30,342 | $17,740 |
| + Debt | $7,119 | $8,531 | $9,778 | $773 |
| Enterprise Value | $2,915 | $9,423 | -$1,737 | $47,729 |
| Revenue | $1,269 | $1,080 | $493 | $0 |
| % Growth | 17.5% | 119.1% | – | – |
| Gross Profit | -$5,740 | -$1,365 | -$1,239 | $0 |
| % Margin | -452.3% | -126.4% | -251.3% | – |
| EBITDA | -$35,578 | -$48,260 | -$74,786 | -$39,393 |
| % Margin | -2,803.6% | -4,468.5% | -15,169.6% | – |
| Net Income | -$58,795 | -$19,769 | -$76,100 | -$18,003 |
| % Margin | -4,633.2% | -1,830.5% | -15,436.1% | – |
| EPS Diluted | -177.3 | -361.16 | -5,715.36 | -2,695.87 |
| % Growth | 50.9% | 93.7% | -112% | – |
| Operating Cash Flow | -$27,793 | -$49,270 | -$44,058 | -$50,044 |
| Capital Expenditures | -$20 | -$203 | -$639 | -$1,484 |
| Free Cash Flow | -$27,813 | -$49,473 | -$44,697 | -$51,528 |